• Can Yoga Reduce Symptoms of IBS?

Can Yoga Reduce Symptoms of IBS?

Yoga might be a feasible and safe adjunct treatment for irritable bowel syndrome (IBS), a systematic review shows in the December issue of Clinical Gastroenterology and Hepatology. The review found evidence for beneficial effects of yoga on gastrointestinal (GI) symptoms, quality of life, and anxiety, although further studies are needed. IBS is

Read more
  • Do Patients Continue Behavioral, Relaxation, and Dietary Strategies for IBS?

Do Patients Continue Behavioral, Relaxation, and Dietary Strategies for IBS?

A combination of cognitive behavioral therapy, relaxation, and dietary strategies reduced symptoms and increased quality of life in patients with irritable bowel syndrome (IBS), compared with usual care, researchers report in the February issue of Clinical Gastroenterology and Hepatology. The program produced sustainable behavioral changes in almost all participants after

Read more
  • Should All Patients with IBS be Screened for Celiac Disease?

Should All Patients with IBS be Screened for Celiac Disease?

Screening patients with irritable bowel syndrome (IBS) or other functional gastrointestinal disorders for celiac disease isn’t much more effective than screening the general population, researchers report in the November issue of Clinical Gastroenterology and Hepatology. Celiac disease produces symptoms similar to those of IBS, such as lower abdominal pain, diarrhea,

Read more
  • What Causes Visceral Hypersensitivity in Patients with Irritable Bowel Syndrome?

What Causes Visceral Hypersensitivity in Patients with Irritable Bowel Syndrome?

Colon tissues from patients with irritable bowel syndrome (IBS) produce increased levels of specific polyunsaturated fatty acid (PUFA) metabolites, which stimulate sensory neurons to generate visceral hypersensitivity. This occurs via activation of transient receptor potential (TRP) cation channels, researchers show in the August issue of Gastroenterology. IBS is characterized by abdominal

Read more
  • New Approaches to IBS and IBD, But Concerns About PPIs, Highlighted at DDW

New Approaches to IBS and IBD, But Concerns About PPIs, Highlighted at DDW

A new test to identify diarrhea-predominant irritable bowel syndrome (D-IBS) and a new class of drugs to treat ulcerative colitis were presented at Digestive Disease Week (DDW) in Washington DC, May 15–19. Researchers also warned that many residents of nursing homes are being inappropriately given proton pump inhibitors (PPIs). Mark Pimentel

Read more
  • Do Kids with Abdominal Pain Become Adults with Abdominal Pain?

Do Kids with Abdominal Pain Become Adults with Abdominal Pain?

A large proportion of children with functional abdominal pain still have frequent abdominal pain in adolescence and young adulthood, even though fewer than 1% have a gastrointestinal (GI) disease, researchers report in the December issue of Clinical Gastroenterology and Hepatology. Chronic or recurrent abdominal pain is common in childhood, affecting

Read more

How Does an Antibiotic Reduce Symptoms of IBS?

Rifaximin alters the intestinal microbiota to prevent inflammation and visceral hyperalgesia in stressed rats, according to the February issue of Gastroenterology. These findings could explain the ability of this antibiotic to relieve symptoms of irritable bowel syndrome (IBS) in patients. Rifaximin is a broad-spectrum antibiotic that has been approved by

Read more

New Treatment for IBS

LX1031, a drug that inhibits serotonin production, relieves symptoms and increases stool consistency in patients with nonconstipating irritable bowel syndrome (IBS), according to a study by Philip Brown et al. in the August issue of Gastroenterology. Serotonin (also called 5-hydroxytryptamine or 5-HT) is a neurotransmitter that controls mood and cognition, as

Read more